Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fisetin for Fatigue in Older Cancer Survivors
NCT06819254Phase 4Recruiting
- Sponsor
- Wake Forest University Health Sciences
- Start
- Dec 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of fisetin in fatigue (2 arms), sponsored by Wake Forest University Health Sciences. Primary endpoint: Pittsburgh Fatigability Scale at 12 weeks. Started Dec 2025; status: recruiting.
02
Drugs
fisetin
03
Conditions
fatigue
Beyond the preview
Go deeper on NCT06819254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06819254.